Arctic Bioscience (Norway) Buy Hold or Sell Recommendation
| ABS Stock | NOK 1.86 0.08 4.12% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Arctic Bioscience AS is 'Strong Sell'. The recommendation algorithm takes into account all of Arctic Bioscience's available fundamental, technical, and predictive indicators you will find on this site.
Check out Arctic Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Arctic and provide practical buy, sell, or hold advice based on investors' constraints. Arctic Bioscience AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Arctic |
Execute Arctic Bioscience Buy or Sell Advice
The Arctic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Arctic Bioscience AS. Macroaxis does not own or have any residual interests in Arctic Bioscience AS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Arctic Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Arctic Bioscience Trading Alerts and Improvement Suggestions
| Arctic Bioscience generated a negative expected return over the last 90 days | |
| Arctic Bioscience has high historical volatility and very poor performance | |
| Arctic Bioscience may become a speculative penny stock | |
| Arctic Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 21.52 M. Net Loss for the year was (42.58 M) with profit before overhead, payroll, taxes, and interest of 5.8 M. | |
| Arctic Bioscience generates negative cash flow from operations | |
| About 55.0% of the company shares are held by company insiders |
Arctic Bioscience Returns Distribution Density
The distribution of Arctic Bioscience's historical returns is an attempt to chart the uncertainty of Arctic Bioscience's future price movements. The chart of the probability distribution of Arctic Bioscience daily returns describes the distribution of returns around its average expected value. We use Arctic Bioscience AS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Arctic Bioscience returns is essential to provide solid investment advice for Arctic Bioscience.
| Mean Return | -1.54 | Value At Risk | -15.97 | Potential Upside | 13.22 | Standard Deviation | 13.94 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Arctic Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Arctic Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arctic Bioscience or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arctic Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arctic stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.59 | |
β | Beta against Dow Jones | 0.33 | |
σ | Overall volatility | 14.04 | |
Ir | Information ratio | -0.12 |
Arctic Bioscience Volatility Alert
Arctic Bioscience AS is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arctic Bioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arctic Bioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Arctic Bioscience Fundamentals Vs Peers
Comparing Arctic Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arctic Bioscience's direct or indirect competition across all of the common fundamentals between Arctic Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arctic Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Arctic Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Arctic Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Arctic Bioscience to competition |
| Fundamentals | Arctic Bioscience | Peer Average |
| Return On Equity | -0.22 | -0.31 |
| Return On Asset | -0.11 | -0.14 |
| Profit Margin | (1.98) % | (1.27) % |
| Operating Margin | (1.86) % | (5.51) % |
| Current Valuation | 145.21 M | 16.62 B |
| Shares Outstanding | 24.38 M | 571.82 M |
| Shares Owned By Insiders | 55.06 % | 10.09 % |
| Shares Owned By Institutions | 9.01 % | 39.21 % |
| Price To Book | 1.05 X | 9.51 X |
| Price To Sales | 14.73 X | 11.42 X |
| Revenue | 21.52 M | 9.43 B |
| Gross Profit | 5.8 M | 27.38 B |
| EBITDA | (39.72 M) | 3.9 B |
| Net Income | (42.58 M) | 570.98 M |
| Book Value Per Share | 13.19 X | 1.93 K |
| Cash Flow From Operations | (39.49 M) | 971.22 M |
| Earnings Per Share | (1.75) X | 3.12 X |
| Target Price | 15.0 | |
| Number Of Employees | 13 | 18.84 K |
| Market Capitalization | 276.66 M | 19.03 B |
| Total Asset | 341.47 M | 29.47 B |
| Net Asset | 341.47 M |
Arctic Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Arctic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Arctic Bioscience Buy or Sell Advice
When is the right time to buy or sell Arctic Bioscience AS? Buying financial instruments such as Arctic Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Arctic Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.